Company Filing History:
2 out of 3,684 
2 out of 101 Years Active: 2007-2011
Title: Jun Wen - Innovator in N-Heterocyclic Compounds
Introduction
Jun Wen is a notable inventor based in Dayton, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on N-heterocyclic compounds. With a total of 2 patents, his research focuses on the inhibition of TNF-alpha expression, which has important implications for treating various medical conditions.
Latest Patents
Jun Wen's latest patents include the development of N-heterocyclic inhibitors of TNF-alpha expression. These compounds are designed to block cytokine production by inhibiting p38 kinase activity. The patents disclose methods of production, pharmaceutical compositions, and treatment methods for conditions associated with inappropriate p38 kinase activity or TNF-alpha expression. The compounds are represented by a specific formula, showcasing the innovative nature of his work.
Career Highlights
Throughout his career, Jun Wen has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Pharmacopeia Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Jun Wen has collaborated with notable colleagues such as Gulzar Ahmed and Axel Metzger. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Jun Wen's contributions to the field of pharmaceutical chemistry through his innovative patents on N-heterocyclic compounds highlight his role as a significant inventor. His work continues to influence the development of treatments for conditions related to TNF-alpha expression.